THE ACCEPTABILITY OF A COMBINED ESTROGEN-PROGESTOGEN CONTRACEPTIVE VAGINAL RING

被引:26
|
作者
WEISBERG, E
FRASER, IS
MISHELL, DR
LACARRA, M
BARDIN, CW
机构
[1] UNIV SYDNEY, SYDNEY CTR REPROD HLTH RES, DEPT OBSTET & GYNAECOL, SYDNEY, NSW 2006, AUSTRALIA
[2] POPULAT COUNCIL, CTR BIOMED RES, NEW YORK, NY 10021 USA
[3] UNIV SO CALIF, SCH MED, DEPT OBSTET & GYNECOL, LOS ANGELES, CA 90033 USA
关键词
CONTRACEPTION; ESTROGEN; PROGESTOGEN VAGINA; RING; ACCEPTABILITY;
D O I
10.1016/0010-7824(94)00005-H
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The acceptability of a vaginal ring releasing ethinyl oestradiol 20 meg per day and norethindrone acetate I mg per day was assessed during a six-month phase II trial comparing three different regimens, which was carried out simultaneously in Los Angeles and Sydney. Sixty women were enrolled in Sydney and 90 in Los Angeles. On admission into the study, the women were asked to complete a questionnaire which gave details of age, last contraceptive method used, contraceptive methods used in the past and their reason for liking or disliking previous contraceptive methods, as well as their reason for stopping the last method. On completion of the study or leaving the study for any reason, each woman was asked to complete an acceptability questionnaire which included her experiences with the ring and the rating of the method. The responses to these two questionnaires form the basis of this report. The overall rating of the ring was similar in both the Sydney and Los Angeles groups. Sixty-nine percent of women rated the method as very good. Seventy-two percent of women in Los Angeles and 62% of women in Sydney liked the ring much more than their most liked previous method. In both groups the method they liked best apart from the ring was the pill (62% in Sydney and 53% in Los Angeles), The major reasons for liking the ring were convenience of use, effectiveness and no requirements for taking medication daily. Most women in both studies would recommend the ring to others (92% in Sydney and 89% in Los Angeles).
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [31] Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring
    Roumen, FJME
    Dieben, TOM
    CONTRACEPTION, 1999, 59 (01) : 59 - 62
  • [32] The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age
    Han, Yi
    Zou, Shi-En
    Long, Qi-Qi
    Zhang, Shao-Fen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (07): : 583 - 588
  • [33] Prevalence of combined contraceptive vaginal rings in Norway
    Skipenes, Vanja Poppe
    Skjeldestad, Finn Egil
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (09) : 1027 - 1033
  • [34] COMPARISON OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST GOSERELIN ACETATE ALONE VERSUS GOSERELIN COMBINED WITH ESTROGEN-PROGESTOGEN ADD-BACK THERAPY IN THE TREATMENT OF ENDOMETRIOSIS
    KIILHOLMA, P
    KORHONEN, M
    TUIMALA, R
    HAGMAN, E
    KIVINEN, S
    FERTILITY AND STERILITY, 1995, 64 (05) : 903 - 908
  • [35] Extended regimens of the vaginal contraceptive ring: cycle control
    Falbo Guazzelli, Cristina Aparecida
    Barreiros, Fernando Augusto
    Barbosa, Ricardo
    de Araujo, Fabio Fernando
    Moron, Antonio Fernandes
    CONTRACEPTION, 2009, 80 (05) : 430 - 435
  • [36] Factors associated with willingness to use the contraceptive vaginal ring
    Gilliam, Melissa
    Holmquist, Sabriina
    Berlin, Amy
    CONTRACEPTION, 2007, 76 (01) : 30 - 34
  • [37] Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women
    Shapley-Quinn, Mary Kate
    Laborde, Nicole
    Luecke, Ellen
    Hoesley, Craig
    Salata, Robert A.
    Johnson, Sherri
    Nel, Annalene
    Soto-Torres, Lydia
    Chen, Beatrice A.
    van der Straten, Ariane
    AIDS PATIENT CARE AND STDS, 2022, 36 (03) : 97 - 105
  • [38] Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users
    Jensen, Jeffrey T.
    Archer, David F.
    Westhoff, Carolyn L.
    Nelson, Anita L.
    Graham, Shelli
    Bernick, Brian
    JOURNAL OF WOMENS HEALTH, 2023, 32 (07) : 808 - 815
  • [39] Histopathological alterations during breast carcinogenesis in a rat model induced by 7,12-Dimethylbenz (a) anthracene and estrogen-progestogen combinations
    Feng, Man
    Feng, Chang
    Yu, Zhigang
    Fu, Qinye
    Ma, Zhongbing
    Wang, Feng
    Wang, Fei
    Yu, Lixiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 346 - 357
  • [40] Association Between Tampon Use and Choosing the Contraceptive Vaginal Ring
    Tepe, Melissa
    Mestad, Renee
    Secura, Gina
    Allsworth, Jenifer E.
    Madden, Tessa
    Peipert, Jeffrey F.
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (04) : 735 - 739